These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 33489088)

  • 1. Protracted withdrawal syndrome after stopping antidepressants: a descriptive quantitative analysis of consumer narratives from a large internet forum.
    Hengartner MP; Schulthess L; Sorensen A; Framer A
    Ther Adv Psychopharmacol; 2020; 10():2045125320980573. PubMed ID: 33489088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antidepressant medication to prevent depression relapse in primary care: the ANTLER RCT.
    Duffy L; Clarke CS; Lewis G; Marston L; Freemantle N; Gilbody S; Hunter R; Kendrick T; Kessler D; King M; Lanham P; Mangin D; Moore M; Nazareth I; Wiles N; Bacon F; Bird M; Brabyn S; Burns A; Donkor Y; Hunt A; Pervin J; Lewis G
    Health Technol Assess; 2021 Nov; 25(69):1-62. PubMed ID: 34842135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SSRI and SNRI withdrawal symptoms reported on an internet forum.
    Stockmann T; Odegbaro D; Timimi S; Moncrieff J
    Int J Risk Saf Med; 2018; 29(3-4):175-180. PubMed ID: 29758951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant therapy with antidepressants for the management of inflammatory bowel disease.
    Mikocka-Walus A; Prady SL; Pollok J; Esterman AJ; Gordon AL; Knowles S; Andrews JM
    Cochrane Database Syst Rev; 2019 Apr; 4(4):CD012680. PubMed ID: 30977111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. REDUCE (Reviewing long-term antidepressant use by careful monitoring in everyday practice) internet and telephone support to people coming off long-term antidepressants: protocol for a randomised controlled trial.
    Kendrick T; Geraghty AWA; Bowers H; Stuart B; Leydon G; May C; Yao G; O'Brien W; Glowacka M; Holley S; Williams S; Zhu S; Dewar-Haggart R; Palmer B; Bell M; Collinson S; Fry I; Lewis G; Griffiths G; Gilbody S; Moncrieff J; Moore M; Macleod U; Little P; Dowrick C
    Trials; 2020 May; 21(1):419. PubMed ID: 32448374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prospective evaluation of antidepressant discontinuation].
    Mourad I; Lejoyeux M; Adès J
    Encephale; 1998; 24(3):215-22. PubMed ID: 9696914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enduring neurological sequelae of benzodiazepine use: an Internet survey.
    Huff C; Finlayson AJR; Foster DE; Martin PR
    Ther Adv Psychopharmacol; 2023; 13():20451253221145561. PubMed ID: 36760692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain Zaps: An Underappreciated Symptom of Antidepressant Discontinuation.
    Papp A; Onton JA
    Prim Care Companion CNS Disord; 2018 Dec; 20(6):. PubMed ID: 30605268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What I have learnt from helping thousands of people taper off antidepressants and other psychotropic medications.
    Framer A
    Ther Adv Psychopharmacol; 2021; 11():2045125321991274. PubMed ID: 33796265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications.
    Cosci F; Chouinard G
    Psychother Psychosom; 2020; 89(5):283-306. PubMed ID: 32259826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of antidepressant drug discontinuation with taperingstrips after 1-5 years.
    Groot PC; van Os J
    Ther Adv Psychopharmacol; 2020; 10():2045125320954609. PubMed ID: 32953040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacotherapy of mood disorders and treatment discontinuation.
    Lader M
    Drugs; 2007; 67(12):1657-63. PubMed ID: 17683167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Designing withdrawal support services for antidepressant users: Patients' views on existing services and what they really need.
    Read J; Moncrieff J; Horowitz MA
    J Psychiatr Res; 2023 May; 161():298-306. PubMed ID: 36989904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The changing purpose of Prader-Willi syndrome clinical diagnostic criteria and proposed revised criteria.
    Gunay-Aygun M; Schwartz S; Heeger S; O'Riordan MA; Cassidy SB
    Pediatrics; 2001 Nov; 108(5):E92. PubMed ID: 11694676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Pre-Existing Migraine and Other Co-Morbid or Co-Occurring Conditions on Presentation and Clinical Course Following Deployment-Related Concussion.
    Scott BR; Uomoto JM; Barry ES
    Headache; 2020 Mar; 60(3):526-541. PubMed ID: 31898813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ECNP consensus meeting. Bipolar depression. Nice, March 2007.
    Goodwin GM; Anderson I; Arango C; Bowden CL; Henry C; Mitchell PB; Nolen WA; Vieta E; Wittchen HU
    Eur Neuropsychopharmacol; 2008 Jul; 18(7):535-49. PubMed ID: 18501566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The behavioral impact of growth hormone treatment for children and adolescents with Prader-Willi syndrome: a 2-year, controlled study.
    Whitman BY; Myers S; Carrel A; Allen D
    Pediatrics; 2002 Feb; 109(2):E35. PubMed ID: 11826245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety reporting and adverse-event profile of mirtazapine described in randomized controlled trials in comparison with other classes of antidepressants in the acute-phase treatment of adults with depression: systematic review and meta-analysis.
    Watanabe N; Omori IM; Nakagawa A; Cipriani A; Barbui C; McGuire H; Churchill R; Furukawa TA;
    CNS Drugs; 2010 Jan; 24(1):35-53. PubMed ID: 20030418
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.